Prudent Man Advisors’s Pfizer PFE Stock Holding History

Prudent Man Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,129	Closed	-$531K	–	169
2020 Q2	$531K	Buy	+17,129	New	+$582K	0.47%	60

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Prudent Man Advisors's PFE Position: Q3 2020 in Review

Prudent Man Advisors sold out of Pfizer (PFE) in Q3 2020, closing a stake of 17,129 shares — an estimated $531K sold.

Prudent Man Advisors first reported a position in PFE in Q2 2020 and held it in 1 quarter. The position peaked at $531K in Q2 2020. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Prudent Man Advisors reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Prudent Man Advisors sold 17,129 Pfizer shares in Q3 2020, an estimated $531K.
Prudent Man Advisors first reported a position in Pfizer in Q2 2020 and held it in 1 quarter.
Prudent Man Advisors's Pfizer position peaked at $531K in Q2 2020.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Prudent Man Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.